CAPTRUST Financial Advisors
PLXP

CAPTRUST Financial Advisors’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-550
Closed -$1K – 4475
2022
Q2 		$1K Hold
550
– – ﹤0.01% 4825
2022
Q1 		$2K Hold
550
– – ﹤0.01% 4593
2021
Q4 		$4K Hold
550
– – ﹤0.01% 4218
2021
Q3 		$11K Buy
+550
New +$9.61K ﹤0.01% 3581

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

CAPTRUST Financial Advisors's PLXP Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2022, closing a stake of 550 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in PLXP in Q3 2021 and held it in 4 quarters. The position peaked at $11K in Q3 2021. 40 funds tracked by Wall St. Rank hold PLXP as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 550 PLx Pharma Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in PLx Pharma Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's PLx Pharma Inc. Common Stock position peaked at $11K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.